Form 483

Venus Pharmaceuticals International, Inc. Form 483, 2012-01-20

FDA issued a Form 483 to Venus Pharmaceuticals International, Inc. on 2012-01-20 with 9 public-safe observations.

483· Form 483 issued9 observations

Venus Pharmaceuticals International, Inc. · Hauppauge, United States · Issued January 20, 2012

Overview

  • 9 public-safe observations are available for this inspection.
  • 8 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

20 Jan 2012
21 CFR 111.75(a)(1)(i)

Component - verify identity, dietary ingredient

Cited by Meredith P Soehl

20 Jan 2012
21 CFR 111.75(a)(2)(ii)(A)

Component - qualify supplier

Cited by Meredith P Soehl

20 Jan 2012
21 CFR 111.75(c)

Specifications met - verify; finished batch

Cited by Meredith P Soehl

20 Jan 2012
21 CFR 111.123(b)(2)

Quality control - batch, product specifications

Cited by Meredith P Soehl

20 Jan 2012
21 CFR 111.160(c)(1)

Packaging - quarantine; samples

Cited by Meredith P Soehl

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 111.160(c)(3)Cited across public-safe Form 483 observations2x
21 CFR 111.123(b)(2)Cited across public-safe Form 483 observations1x
21 CFR 111.160(c)(1)Cited across public-safe Form 483 observations1x
21 CFR 111.303Cited across public-safe Form 483 observations1x
21 CFR 111.320(b)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(1)(i)Cited across public-safe Form 483 observations1x
21 CFR 111.75(a)(2)(ii)(A)Cited across public-safe Form 483 observations1x
21 CFR 111.75(c)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 9 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere